[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![Sankyo Co. Ltd. Graphic](https://lunarcrush.com/gi/w:26/t:$6417t.png) Sankyo Co. Ltd.

Daiichi Sankyo and AstraZeneca's Enhertu receives FDA Priority Review for HER2+ breast cancer treatment. Music box and flute performances are trending on social media, indicating diverse engagement with the brand.

### About Sankyo Co. Ltd.
Sankyo Co. Ltd. is a company with diverse mentions, including pharmaceutical collaborations, music-related content, and toy promotions.  

### Insights [#](/topic/$6417t/insights)
- Sankyo Co. Ltd. engagements is up XXXXX% from the previous week.

### Price: $ [#](/topic/$6417t/close)
---
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$6417t/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$6417t/time-series/close.tsv)  
The market cap is undefined, but the positive sentiment and mentions of Daiichi Sankyo's collaborations, especially with AstraZeneca, suggest potential positive future price action if the company is publicly traded.  

**1-Year High**: $XXXXX on 2025-09-09  
**1-Year Low**: $XXXXXXXX on 2025-04-07  
  
  
### AltRank: undefined [#](/topic/$6417t/alt_rank)
---
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$6417t/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$6417t/time-series/alt_rank.tsv)  
Sankyo Co. Ltd. is currently AltRank #undefined based on combined combined social and market metrics
**Daily Average**: XXX  
**1-Year High**: XXX on 2024-10-27  
**1-Year Low**: XXX on 2025-01-20  
  
  
### Galaxy Score: XX [#](/topic/$6417t/galaxy_score)
---
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$6417t/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$6417t/time-series/galaxy_score.tsv)  
**Current Value**: XX  
**Daily Average**: XX  
**1-Year High**: XX on 2025-03-07  
**1-Year Low**: XX on 2025-09-13  
  
  
### Engagements: XXXXXX [#](/topic/$6417t/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$6417t/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$6417t/time-series/interactions.tsv)  
**Current Value**: XXXXXX  
**Daily Average**: XXXXXXX  
**1 Week**: XXXXXXX +10%  
**1 Month**: XXXXXXXXX -XX%  
**6 Months**: XXXXXXXXXX +42%  
**1 Year**: XXXXXXXXXX +23%  
**1-Year High**: XXXXXXXXX on 2025-04-01  
**1-Year Low**: XXX on 2025-10-20  

| Social Network | TikTok | X     | YouTube | News | Reddit |
| -------------- | ------ | -     | ------- | ---- | ------ |
| Engagements    | XXXXX  | XXXXX | XXXXXX  | XX   | X      |
  

  
  
### Mentions: XXX [#](/topic/$6417t/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$6417t/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$6417t/time-series/posts_active.tsv)  
**Current Value**: XXX  
**Daily Average**: XXX  
**6 Months**: XXXXX +58%  
**1 Year**: XXXXX +445%  
**1-Year High**: XXX on 2025-07-02  
**1-Year Low**: X on 2025-01-07  

| Social Network | TikTok | X  | YouTube | News | Reddit |
| -------------- | ------ | -  | ------- | ---- | ------ |
| Mentions       | XX     | XX | XXX     | X    | X      |
  

  
  
### Creators: XX [#](/topic/$6417t/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$6417t/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$6417t/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning Sankyo Co. Ltd. in the last XX hours which is down XX% from XXX in the previous XX hours
**Daily Average**: XXX  
**6 Months**: XXXXX +42%  
**1 Year**: XXXXX +194%  
**1-Year High**: XXX on 2025-07-02  
**1-Year Low**: X on 2025-01-07  

The most influential creators that mention Sankyo Co. Ltd. in the last XX hours

| Creator                                                        | Rank | Followers | Posts | Engagements |
| -------                                                        | ---- | --------- | ----- | ----------- |
| [@maveric92283613](/creator/twitter/maveric92283613)           | X    | XXX       | X     | XXX         |
| [@DaiichiSankyoUS](/creator/twitter/DaiichiSankyoUS)           | X    | XXXXX     | X     | XXX         |
| [@MarcJacksonLA](/creator/twitter/MarcJacksonLA)               | X    | XXXXX     | X     | XXX         |
| [@garymonroid](/creator/tiktok/garymonroid)                    | X    | XXXXXX    | X     | XXX         |
| [@vintagefinestshop602](/creator/youtube/vintagefinestshop602) | X    | XXX       | X     | XX          |
| [@schaeffers](/creator/twitter/schaeffers)                     | X    | XXXXXX    | X     | X           |
| [@ruanmartialarts](/creator/tiktok/ruanmartialarts)            | X    | XXXXX     | X     | X           |
| [@daiichisankyoeurope](/creator/youtube/daiichisankyoeurope)   | X    | XXX       | X     | X           |
| [@kuzushikev](/creator/tiktok/kuzushikev)                      | X    | XXX       | X     | X           |

[View More](/list/creators/$6417t/100)
  
  
### Sentiment: XX% [#](/topic/$6417t/sentiment)
---
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$6417t/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$6417t/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XXX% no change  
**1 Month**: XXX% +9%  
**6 Months**: XXX% +16%  
**1 Year**: XXX% +78%  
**1-Year High**: XXX% on 2024-11-01  
**1-Year Low**: X% on 2024-12-31  

**Most Supportive Themes**
- **Daiichi Sankyo and Merck Collaboration:** (35%) Posts highlight the collaboration between Daiichi Sankyo and Merck, particularly regarding breakthrough therapy designations and clinical trial results.
- **Music and Entertainment:** (25%) Posts feature music-related content, including music boxes, flute performances, and musical compositions.
- **Rail Cube Toys:** (15%) Posts showcase Rail Cube toys, emphasizing their educational and creative aspects.
  
**Most Critical Themes**
- **MNC Exits and Closures:** (10%)  Some posts mention the exits of multinational corporations, including Daiichi Sankyo, from certain markets.
- **Cholesterol Hoax Discussion:** (5%)  A post discusses the origins of the "Cholesterol/LDL(ApoB)/Lp(a) causes disease" hoax.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| TikTok  | XXX      | X%  | XXXXX   | X%  | XX       | X% |
| X       | XXXXX    | X%  | XXXXX   | X%  | X        | X% |
| YouTube | XXXXX    | X%  | XXXXXX  | XX% | XXX      | X% |
| News    | XX       | X%  | X       | X%  | X        | X% |
| Reddit  | X        | X%  | X       | X%  | X        | X% |
|         |          |     |         |     |          |    |
| Total   | XXXXX    | XX% | XXXXXX  | XX% | XXX      | X% |
  

  
  
### Market Cap: $undefined [#](/topic/$6417t/market_cap)
---
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$6417t/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$6417t/time-series/market_cap.tsv)  
**Current Value**: $undefined  
**Daily Average**: $XXXXXXXXXXXXXXX  
**1-Year High**: $XXXXXXXXXXXXXXX on 2025-02-05  
**1-Year Low**: $XXXXXXXXXXXXXXX on 2024-12-17  

**Top assets mentioned**
In the posts about Sankyo Co. Ltd. in the last XX hours

[AstraZeneca PLC (AZN)](/topic/$azn)
[Pfizer, Inc. (PFE)](/topic/$pfe)
[Merck & Co., Inc. (MRK)](/topic/$mrk)
[TARIFF MAN (BILLIONS)](/topic/$billions)
[69Coin (69)](/topic/$69)
[Novartis AG (NVS)](/topic/novartis)
[Novo-Nordisk (NVO)](/topic/$nvo)
[Alphabet Inc Class A (GOOGL)](/topic/$googl)
[Seagen Inc (SGEN)](/topic/$sgen)
[Immunogen Inc (IMGN)](/topic/$imgn)

**Top topics mentioned**
In the posts about Sankyo Co. Ltd. in the last XX hours

[$8750t](/topic/$8750t), [$4568t](/topic/$4568t), [stocks healthcare](/topic/stocks-healthcare), [$azn](/topic/$azn), [breast cancer](/topic/breast-cancer), [japan](/topic/japan), [youtube](/topic/youtube), [$pfe](/topic/$pfe), [$6594t](/topic/$6594t), [$mrk](/topic/$mrk), [click the](/topic/click-the), [manat](/topic/manat), [made in](/topic/made-in), [the only](/topic/the-only), [has been](/topic/has-been), [soo](/topic/soo), [xx](/topic/xx), [tokyo](/topic/tokyo), [$billions](/topic/$billions), [$69](/topic/$69), [$dsnky](/topic/$dsnky), [loading](/topic/loading), [trc](/topic/trc), [$7751t](/topic/$7751t), [stocks](/topic/stocks), [investment](/topic/investment), [banda](/topic/banda), [$reymi](/topic/$reymi), [playstation](/topic/playstation), [uc](/topic/uc), [instagram](/topic/instagram), [facebook](/topic/facebook), [rating agency](/topic/rating-agency), [vtuber](/topic/vtuber), [twitter](/topic/twitter), [rio](/topic/rio), [genre](/topic/genre), [$9468t](/topic/$9468t), [lane](/topic/lane), [toys](/topic/toys), [applications](/topic/applications), [$8001t](/topic/$8001t), [worlds first](/topic/worlds-first), [billions](/topic/billions), [clair](/topic/clair), [lune](/topic/lune), [aaj](/topic/aaj), [ho](/topic/ho), [novartis](/topic/novartis), [$nvo](/topic/$nvo), [skincare](/topic/skincare), [dublin](/topic/dublin), [lions](/topic/lions), [hub](/topic/hub), [$cgen](/topic/$cgen), [directed](/topic/directed), [christmas](/topic/christmas), [elements](/topic/elements), [bangladesh](/topic/bangladesh), [$ihhhf](/topic/$ihhhf), [$13b](/topic/$13b), [$googl](/topic/$googl), [stocks communication services](/topic/stocks-communication-services), [safari](/topic/safari), [ella](/topic/ella), [favorites](/topic/favorites), [$ctmx](/topic/$ctmx), [$sgen](/topic/$sgen), [$imgn](/topic/$imgn), [gilead sciences](/topic/gilead-sciences), [indonesia](/topic/indonesia), [yuk](/topic/yuk), [dancer](/topic/dancer), [$2531t](/topic/$2531t), [where is](/topic/where-is), [filter](/topic/filter), [jersey](/topic/jersey), [gigi](/topic/gigi), [san diego](/topic/san-diego), [canada](/topic/canada), [$112bn](/topic/$112bn), [$068270ks](/topic/$068270ks), [adc](/topic/adc), [kindly](/topic/kindly), [carnivore](/topic/carnivore), [positions](/topic/positions), [applied](/topic/applied), [lang](/topic/lang), [edinburgh](/topic/edinburgh), [$8136t](/topic/$8136t), [hello kitty](/topic/hello-kitty), [kitty](/topic/kitty), [jill](/topic/jill), [vintage](/topic/vintage), [castle](/topic/castle), [over the](/topic/over-the), [combo](/topic/combo), [mai](/topic/mai), [alan](/topic/alan), [diving](/topic/diving)

### Top News [#](/topic/$6417t/news)
---
Top news links shared on social in the last XX hours  

*Showing a maximum of X news posts for non-authenticated requests. Use your API key in requests for full results.*  

"AstraZeneca's Enhertu shows promise in early-stage breast cancer treatment"  
[News Link](https://news.yahoo.com/news/articles/astrazenecas-enhertu-shows-promise-early-143341931.html) [@YahooNews](/creator/x/YahooNews) 2025-10-19T17:41Z 208.1M followers, XX engagements



### Top Social Posts [#](/topic/$6417t/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"I have so many questions but what's even funnier is that as a kid I had a vintage Christmas decoration with the SAME exact music box movement that a recording of is being played here. Specifically it's a 14-note Sankyo movement that they stopped making years ago"  
[X Link](https://x.com/TremiRodomi/status/1980061385896636478) [@TremiRodomi](/creator/x/TremiRodomi) 2025-10-19T23:59Z XX followers, XXX engagements


"AstraZeneca's Enhertu shows promise in early-stage breast cancer treatment Shorts"  
[YouTube Link](https://youtube.com/watch?v=w_E1LIH2YL8) [@healthandfitnessworld2x](/creator/youtube/healthandfitnessworld2x) 2025-10-19T17:41Z 1030 followers, XX engagements


"#BREAKINGNEWS: During @MyESMO Daiichi Sankyo announced data from our TA-MUC1 directed DXd ADC first-in-human phase 1/2 trial. This is the sixth DXd ADC from our oncology pipeline. Click to learn more & follow us during #ESMO25 for the latest data updates from Daiichi Sankyo"  
[X Link](https://x.com/DaiichiSankyoUS/status/1979901319180902826) [@DaiichiSankyoUS](/creator/x/DaiichiSankyoUS) 2025-10-19T13:23Z 4424 followers, XXX engagements


"#BREAKINGNEWS: Today at @MyESMO Daiichi Sankyo announced results from the phase X part of the REJOICE-Ovarian01 phase 2/3 trial in certain patients with platinum-resistant ovarian cancer. Click the image to learn more. #OvarianCancer #CancerResearch #ESMO25"  
[X Link](https://x.com/DaiichiSankyoUS/status/1979897206326059271) [@DaiichiSankyoUS](/creator/x/DaiichiSankyoUS) 2025-10-19T13:07Z 4424 followers, XXX engagements